Your browser doesn't support javascript.
loading
Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity.
Christianson, Helena C; Menard, Julien A; Indira Chandran, Vineesh; Bourseau-Guilmain, Erika; Shevela, Dmitry; Lidfeldt, Jon; Månsson, Ann-Sofie; Pastorekova, Silvia; Messinger, Johannes; Belting, Mattias.
Afiliación
  • Christianson HC; Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden.
  • Menard JA; Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden.
  • Indira Chandran V; Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden.
  • Bourseau-Guilmain E; CNRS UMR 5237 CRBM, Montpellier University, Montpellier, France.
  • Shevela D; Department of Chemistry, Chemical Biological Centre, Umeå University, Umeå, Sweden.
  • Lidfeldt J; Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden.
  • Månsson AS; Department of Clinical Sciences, Section of Oncology and Pathology, Lund University, Lund, Sweden.
  • Pastorekova S; Biomedical Research Centre, Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Messinger J; Department of Chemistry, Chemical Biological Centre, Umeå University, Umeå, Sweden.
  • Belting M; Department of Chemistry - Ångström, Molecular Biomimetics, Uppsala University, Uppsala, Sweden.
Oncotarget ; 8(40): 66960-66974, 2017 09 15.
Article en En | MEDLINE | ID: mdl-28978009
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia